Target intelligence / Profile preview

Epidermal keratin and protein disulfide bonds

Molecular classification
Structural protein, Intermediate filament
01

Overview

Epidermal keratins are fibrous structural proteins that constitute the primary component of the intermediate filament cytoskeleton in epithelial cells, providing essential mechanical stability and barrier function to the skin (UniProt, P13645; NIH, NBK560714). These proteins are characterized by a high content of cysteine residues, which form extensive intra- and intermolecular disulfide bonds that cross-link the keratin filaments into a dense, resilient matrix (Journal of Investigative Dermatology, 2015). In the stratum corneum, this keratinized structure is vital for protecting the body against environmental stressors, pathogens, and dehydration (StatPearls, NBK560714). From a therapeutic perspective, these proteins and their stabilizing disulfide bonds are targeted by two main classes of agents: keratolytics and depilatories (PubChem, CID 1133). Keratolytic agents, such as salicylic acid and high-concentration urea, work by disrupting the hydrogen bonds and intercellular adhesion within the keratin matrix to promote the shedding of dead skin cells in conditions like psoriasis and hyperkeratosis (StatPearls, NBK560714). Conversely, depilatory agents like thioglycolic acid salts target the disulfide bonds directly, reducing them to thiol groups, which weakens the hair's structural integrity and allows for its mechanical removal (PubChem, CID 1133). Understanding the biochemical properties of these bonds is crucial for developing treatments that balance efficacy in protein degradation with the maintenance of skin health.

Other names
KeratinCytokeratinDisulfide bridgesCystine bondsIntermediate filamentsKRT
02

Mechanism of action

Chemical reduction of disulfide bonds to destabilize protein structure (depilatories) or disruption of hydrogen bonding and intercellular adhesion to facilitate desquamation (keratolytics).

03

Biological functions

Structural integrityBarrier functionProtection from mechanical stressKeratinizationDesquamation
04

Disease associations

HyperkeratosisPsoriasisIchthyosisAcne vulgarisHirsutismCallus
05

Safety considerations

Skin irritationChemical burnsContact dermatitisSystemic salicylate toxicitySensitization
06

Interacting drugs

Salicylic acid

5 more in the full profile.

07

Biomarkers

Keratin 10 (K10) expressionKeratin 1 (K1) expressionStratum corneum thicknessTransepidermal water loss (TEWL)

Beyond the preview

Go deeper on Epidermal keratin and protein disulfide bonds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal keratin and protein disulfide bonds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call